Defendant Fact Sheet Protocol Released For PPI Lawsuits
Defendant Fact Sheet Protocol Released For PPI Lawsuits
Introduction
In an order issued on July 30, the federal court overseeing the Proton Pump Inhibitor (PPI) litigation, established the form, procedure, and schedule for the completion and service of Defendant Fact Sheets (DFS).
The court announced that a completed Plaintiff Face Sheet (PFS) must be served by all the defendants either within 120 days from the date of the order's entry or within 120 days from the date on which the PFS is considered complete. If the PFS is served after July 30, the DFS must be served within 90 days from the date of PFS completion. Additionally, the order also states, any defendant can request via an email to the Plaintiffs' Counsel to get a 30 days extension to submit a completed DFS, which cannot be unreasonably withheld by the plaintiff.
The defendants involved in the litigation are AstraZeneca Pharmaceuticals LP, Procter & Gamble Co., McKesson Corp., Takeda Pharmaceuticals USA Inc., Novartis Pharmaceuticals Corp., and Pfizer Inc.
More than 4,700 lawsuits are filed by individuals claiming the PPI manufacturers failed to warn them about kidney failure and other renal complications due to the long-term use of Nexium, Prilosec, PrevAcid, Protonix, or Dexilant. PPI lawsuits were centralized on August 2, 2017, as a part of the multidistrict litigation (MDL No. 2789; In Re: Proton-Pump Inhibitor Products Liability Litigation [No. II]) overlooked by Judge Claire C. Cecchi in the District of New Jersey.
Latest News
title demo for news
Zantac Settles 4,000 Lawsuits in U.S. Courts
Sanofi has announced a settlement agreement regarding approximately 4,000 Zantac cancer lawsuits filed in state courts across the country.
…Valsartan Recall Lawsuit Set for Trial
Years after the initiation of Valsartan recalls, the U.S. District Judge overseeing lawsuits filed by individuals harmed by tainted versions of…